Hao Chi Zhang, MD

University of Texas MD Anderson Cancer Center

Poster(s):

• P2508 - Implementation of an Enhanced "Step-Up" Approach Towards Early Tocilizumab for Management of Immune Checkpoint Inhibitor-Mediated Hepatotoxicity: A Case Study in Revisiting Paradigms of Treatment
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT

• P2509 - Early Tocilizumab as a Rescue Therapy for Steroid-Dependent Immune Checkpoint Inhibitor-Mediated Hepatotoxicity: A Case for Decoupling Steroid Dependency
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT

• P2510 - Mogamulizumab-Induced Cholangiopathy in a Patient With Cutaneous T-Cell Lymphoma: A Case Study
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT